Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer
- 1 September 1972
- Vol. 30 (3), 654-659
- https://doi.org/10.1002/1097-0142(197209)30:3<654::aid-cncr2820300312>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Prolonged low-dosage administration of hexamethylmelamine (NC 13875)Cancer, 1970
- Phase II study of hexamethylmelamine (NSC 13875)Cancer, 1969
- Plasma levels and urinary excretion of hexamethylmelamine following oral administration to human subjects with cancerClinical Pharmacology & Therapeutics, 1968
- Hexamethylmelamine (NSC-13875) in the treatment of primary cancer of the lung with metastasisCancer, 1968
- Insect Chemosterilants. V. Derivatives of MelamineJournal of Medicinal Chemistry, 1967
- The clinical pharmacology of hexamethylmelamine: Phase I studyClinical Pharmacology & Therapeutics, 1967
- Meaningful clinical classification of therapeutic responses to anticancer drugsClinical Pharmacology & Therapeutics, 1961